Advertisement
MTD vs SYK
Which Stock Would AI Choose? Mettler-Toledo (MTD) vs. Stryker (SYK) Stock Comparison
Key Takeaways
- MTD (Mettler-Toledo) beat first-quarter earnings expectations, raised full-year guidance, and announced a large buyback, signaling strong cash generation.
- SYK (Stryker) delivered a sharp second-quarter recovery after a cybersecurity disruption, with roughly 9% organic sales growth and an earnings beat.
- Analyst sentiment is markedly more constructive on SYK (consensus "Buy") than on MTD (consensus "Hold").
- The two companies operate in different niches—precision laboratory and industrial instruments versus medical devices—making their risk profiles distinct.
- Relative performance and market positioning diverged recently, with SYK trading below its recent range while MTD sits near its 52-week highs.
Introduction
Investors comparing MTD (Mettler-Toledo International) and SYK (Stryker Corporation) are weighing two very different healthcare-adjacent franchises. Mettler-Toledo supplies precision weighing and analytical instruments to laboratories, pharmaceutical, and industrial customers, while Stryker is a global medical-technology leader in orthopedics, surgical equipment, and neurotechnology. This stock comparison is relevant for investors assessing growth-versus-valuation trade-offs, exposure to medical capital equipment, and how each company navigates a shifting macroeconomic and operational environment. Both carry meaningful sensitivity to tariffs, demand cycles, and end-market health, yet their business models and recent catalysts point in different directions.
MTD Overview and Recent Performance
MTD is a Swiss-headquartered manufacturer of precision instruments used in laboratory, industrial, food-retail, and product-inspection applications, with a substantial recurring service revenue stream. In recent weeks, the company's market positioning improved after first-quarter 2026 results showed local-currency sales growth of roughly 3%, an earnings-per-share beat, and raised full-year adjusted EPS (earnings per share) guidance to 8%–10% growth. Management also announced an $875 million share-repurchase program, underscoring confidence in cash generation.
Despite these positives, relative performance has been uneven. The shares lost ground earlier in the year and lagged the broader S&P 500 for much of 2026, though recent analyst actions—including price-target increases from firms such as BofA and Barclays—have been supportive. The primary sentiment overhang remains softer demand and delayed equipment-replacement cycles in Europe and China, as well as tariff-related cost pressure. With a consensus "Hold" rating and an average price target slightly below recent trading levels, the market appears to be pricing in a measured, margin-led recovery rather than rapid top-line acceleration.
SYK Overview and Recent Performance
SYK is one of the largest medical-device companies in the world, spanning reconstructive orthopedics (hips, knees, trauma), MedSurg and Neurotechnology (endoscopy, hospital beds, neurovascular devices), and a fast-growing robotics franchise led by its Mako platform. The company's recent activity has been dominated by an operational disruption: a cybersecurity incident in the first quarter temporarily halted ordering, shipping, and manufacturing, causing a revenue and earnings miss.
In subsequent quarters, however, Stryker demonstrated a clear recovery. Second-quarter results showed revenue growth of roughly 9.4% and adjusted EPS up 17.9% year over year, with margins expanding as production normalized. Management narrowed full-year organic sales growth guidance to about 8.3%–9.3%. The stock nonetheless trades below its 52-week highs and below its historical valuation premium, reflecting lingering execution concerns around vascular supply constraints, cyber-remediation costs, and a planned CEO transition. Analysts remain broadly constructive, with a consensus "Buy" rating and an average price target implying meaningful upside.
Trending AI Robots
For traders seeking a data-driven edge in evaluating names like MTD and SYK, Tickeron's Trending AI Robots page curates a focused selection of AI trading bots. Tickeron maintains hundreds of AI Trading Bots that trade thousands of different tickers, but only the strongest performers best suited to current market conditions earn a place in this curated section. These bots span a wide range of trading styles, strategies, timeframes, performance statistics, and ticker universes, allowing users to match a bot's approach to their own objectives. Whether you are interested in short-term momentum or longer-horizon positioning, the page offers a practical way to review how algorithmic strategies are currently navigating the market. Explore the Trending AI Robots to see which signals are being prioritized today.
Head-to-Head Comparison
The core contrast between these two stocks is one of growth profile versus valuation discipline. SYK generates significantly larger revenue (roughly $6.6 billion in its most recent quarter versus about $947 million for MTD) and operates in a more secular-growth market driven by aging demographics and surgical procedure volumes. Its robotics franchise and product pipeline provide identifiable multiyear catalysts. MTD, by contrast, is a higher-margin, cash-generative instruments business whose growth is more cyclical and tied to laboratory capital spending and replacement cycles.
Risk factors also diverge. SYK's near-term risks are company-specific and operational—cyber-remediation, supply-chain constraints, and leadership succession—while MTD's are more macroeconomic, including European and Chinese demand softness and tariff exposure. Sector exposure differs meaningfully: SYK is a pure-play medical-device leader, whereas MTD blends healthcare, industrial, and food-retail end markets. On market sentiment, SYK enjoys a more favorable analyst consensus, while MTD's valuation and recent buyback highlight disciplined capital allocation.
Tickeron AI Verdict
Based on observable trend consistency, relative positioning, and catalyst visibility, Tickeron's AI would likely favor SYK in the current environment. The company's recent earnings momentum, a recovering growth trajectory after an operational setback, a deeper product pipeline, and a more constructive analyst consensus all suggest a more durable upward bias. MTD offers stability, strong cash generation, and margin resilience, but its cyclical, replacement-driven demand and consensus "Hold" posture indicate less near-term upside conviction. These are probabilistic assessments based on available data, not guarantees of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and SYK is a StrongBuy.
MTD in upward trend: 10-day moving average broke above 50-day moving average on September 24, 2026
The 10-day moving average for MTD crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for MTD just turned positive on September 17, 2026. Looking at past instances where MTD's MACD turned positive, the stock continued to rise in 31 of 48 cases over the following month. The odds of a continued upward trend are 65%.
Following a +3.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTD advanced for three days, in 193 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 131 of 225 cases where MTD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
MTD broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. MTD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MTD's P/B Ratio (2621.863) is very high in comparison to the industry average of (66.046). P/E Ratio (37.723) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (2.869) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (6.798) is also within normal values, averaging (9.775).
SYK in upward trend: price rose above 50-day moving average on October 20, 2026
SYK moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 57%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SYK as a result. In 48 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for SYK just turned positive on September 28, 2026. Looking at past instances where SYK's MACD turned positive, the stock continued to rise in 23 of 44 cases over the following month. The odds of a continued upward trend are 52%.
Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYK advanced for three days, in 171 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
SYK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SYK entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.759) is normal, around the industry mean (2.874). P/E Ratio (30.586) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MTD | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 87 | 76 | |
SMR RATING 1..100 | 3 | 52 | |
PRICE GROWTH RATING 1..100 | 6 | 56 | |
P/E GROWTH RATING 1..100 | 31 | 83 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (76) in the Medical Specialties industry is in the same range as MTD (99). This means that SYK’s stock grew similarly to MTD’s over the last 12 months.
SYK's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as MTD (87). This means that SYK’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for SYK (52). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
MTD's Price Growth Rating (6) in the Medical Specialties industry is somewhat better than the same rating for SYK (56). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
MTD's P/E Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for SYK (83). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
| MTD | SYK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 66% | 1 day ago 50% |
| Momentum ODDS (%) | N/A | 1 day ago 53% |
| MACD ODDS (%) | 4 days ago 65% | 1 day ago 52% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 60% | 1 day ago 50% |
| Advances ODDS (%) | 1 day ago 61% | 3 days ago 56% |
| Declines ODDS (%) | 22 days ago 66% | 9 days ago 52% |
| BollingerBands ODDS (%) | 1 day ago 61% | 1 day ago 70% |
| Aroon ODDS (%) | 1 day ago 58% | 1 day ago 45% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 3 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).
- MTD’s FA Score: 3 green, 2 red.
- SYK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
- MTD’s TA Score: 4 bullish, 4 bearish.
- SYK’s TA Score: 4 bullish, 5 bearish.
Price Growth
MTD (@Medical Specialties) experienced а +2.78% price change this week, while SYK (@Medical/Nursing Services) price change was +5.67% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
MTD is expected to report earnings on Nov 05, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical Specialties (-3.29% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.